NYSE: PSX

Phillips 66

CIK 0001534701 · SIC 2911 · Petroleum Refining

Mega Revenue $132.4B Assets $81.8B as of Sep 27, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.

8-K Filed Oct 5, 2026 · Period ending Sep 29, 2026

Summary not yet generated.

8-K Filed Aug 21, 2026 · Period ending Aug 20, 2026

Phillips 66 expands receivables securitization to $2B, extends maturity to Aug 2027

3 material changes detected. Sign up free to read the summary.

Partner

Trade PSX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 5, 2026 · Period ending Aug 5, 2026

Summary not yet generated.

10-Q Filed Aug 5, 2026 · Period ending Jun 30, 2026

Phillips 66 Q2 2026 net income surges 339% to $3.85B

4 material changes detected. Sign up free to read the summary.

8-K Filed May 14, 2026 · Period ending May 13, 2026

Summary not yet generated.

10-Q Filed Apr 29, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Feb 20, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

424B3 Filed Sep 16, 2025

Summary not yet generated.

10-Q Filed Jul 28, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 21, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B3 Filed Sep 9, 2024

Summary not yet generated.

424B3 Filed Feb 26, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 5, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statement of Income

Millions of Dollars

Description Three months ended June 30 2026 Three months ended June 30 2025 Six months ended June 30 2026 Six months ended June 30 2025
Revenues and Other Income
Sales and other operating revenues 51,004 33,323 83,544 63,753
Equity in earnings of affiliates 635 153 887 306
Net gain (loss) on dispositions 117 (93) 123 994
Other income 288 139 492 195
Total Revenues and Other Income 52,044 33,522 85,046 65,248
Costs and Expenses
Purchased crude oil and products 43,664 29,077 72,880 56,737
Operating expenses 1,810 1,440 3,691 3,062
Selling, general and administrative expenses 538 582 1,075 1,101
Depreciation and amortization 585 816 1,143 1,607
Impairments 9 4 17 30
Taxes other than income taxes 127 218 361 451
Accretion on discounted liabilities 13 10 25 22
Interest and debt expense 314 264 600 485
Foreign currency transaction (gains) losses 13 (9) 23 (15)
Total Costs and Expenses 47,073 32,402 79,815 63,480
Income before income taxes 4,971 1,120 5,231 1,768
Income tax expense 1,092 212 1,133 334
Net Income 3,879 908 4,098 1,434
Less: net income attributable to noncontrolling interests 32 31 44 70
Net Income Attributable to Phillips 66 3,847 877 4,054 1,364
Net Income Attributable to Phillips 66 Per Share of Common Stock (dollars)
Basic 9.59 2.15 10.09 3.33
Diluted 9.55 2.15 10.05 3.32
Weighted-Average Common Shares Outstanding (thousands)
Basic 400,954 406,763 401,493 407,966
Diluted 402,618 407,929 403,472 409,448
See Notes to Consolidated Financial Statements.

Consolidated Balance Sheet

Millions of Dollars

Description June 30 2026 December 31 2025
Assets
Cash and cash equivalents 4,099 1,116
Accounts and notes receivable (net of allowances of $66 million in 2026 and $68 million in 2025) 11,052 9,158
Accounts and notes receivable—related parties 665 613
Inventories 5,922 5,097
Prepaid expenses and other current assets 2,483 1,287
Total Current Assets 24,221 17,271
Investments and long-term receivables 12,347 11,905
Net properties, plants and equipment 39,649 39,097
Goodwill 1,433 1,433
Intangibles 955 978
Other assets 3,205 2,996
Total Assets 81,810 73,680
Liabilities
Accounts payable 11,643 8,581
Accounts payable—related parties 406 286
Short-term debt 1,797 1,038
Accrued income and other taxes 2,012 1,362
Employee benefit obligations 497 680
Other accruals 1,999 1,379
Total Current Liabilities 18,354 13,326
Long-term debt 18,768 18,678
Asset retirement obligations and accrued environmental costs 1,082 1,022
Deferred income taxes 7,448 7,308
Employee benefit obligations 592 573
Other liabilities and deferred credits 2,863 2,532
Total Liabilities 49,107 43,439
Equity
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2026—661,175,772 shares; 2025—659,391,484 shares)
Par value 7 7
Capital in excess of par 20,063 19,948
Treasury stock (at cost: 2026—262,154,856 shares; 2025—258,252,603 shares) (24,578) (23,934)
Retained earnings 36,270 33,239
Accumulated other comprehensive loss (256) (167)
Total Stockholders’ Equity 31,506 29,093
Noncontrolling interests 1,197 1,148
Total Equity 32,703 30,241
Total Liabilities and Equity 81,810 73,680

Consolidated Statement of Cash Flows

Millions of Dollars

Description Six months ended June 30 2026 Six months ended June 30 2025
Cash Flows From Operating Activities
Net income 4,098 1,434
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 1,143 1,607
Impairments 17 30
Accretion on discounted liabilities 25 22
Deferred income taxes 133 (181)
Undistributed equity earnings (600) 195
Net gain on dispositions (123) (994)
Unrealized investment loss 17 14
Other 306 52
Working capital adjustments
Accounts and notes receivable (2,184) (843)
Inventories (858) (1,607)
Prepaid expenses and other current assets (1,199) (426)
Accounts payable 3,159 1,075
Taxes and other accruals 1,061 654
Net Cash Provided by Operating Activities 4,995 1,032
Cash Flows From Investing Activities
Capital expenditures and investments (1,308) (1,010)
Acquisitions, net of cash acquired (179) (2,220)
Return of investments in equity affiliates 41 43
Proceeds from asset dispositions 71 2,031
Other 31 13
Net Cash Used in Investing Activities (1,344) (1,143)
Cash Flows From Financing Activities
Issuance of debt 6,889 3,499
Repayment of debt (5,901) (2,375)
Issuance of common stock 101 25
Repurchase of common stock (648) (666)
Dividends paid on common stock (1,017) (956)
Distributions to noncontrolling interests (46) (95)
Contributions from noncontrolling interests 51 106
Other (56) (61)
Net Cash Used in Financing Activities (627) (523)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (41) 40
Net Change in Cash and Cash Equivalents, including cash classified within Assets held for sale 2,983 (594)
Cash and cash equivalents at beginning of period 1,116 1,738
Cash and Cash Equivalents at End of Period, including cash classified within Assets held for sale 4,099 1,144

Amounts as printed on the EDGAR/iXBRL face — Millions of Dollars. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing